Dentsply Sirona Inc (XRAY)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $1.83B
Last updated: Nov 17, 2026 at 11:06 AM ET
Dentsply Sirona Inc (XRAY) Earnings: Report Dates and Results
Dentsply Sirona (XRAY) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Dentsply Sirona reported EPS of $0.29, below the $0.30 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
XRAY has an expected report date of Feb 24, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 14.8% above the $0.27 reported for the quarter ended Dec 31, 2025.
XRAY Earnings Call
The latest XRAY earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, XRAY beat 25, missed 11 and matched 4. Revenue for the quarter ended Sep 30, 2026 was $836.00M, down 7.5% from $904.00M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.29 | $0.30 | $0.26 - $0.34 | -3.33% | Miss | -21.6% | 16 | 0 up, 1 down | Nov 5, 2026 | $836.00M |
| Jun 30, 2026 | $0.52 | $0.36 | $0.31 - $0.42 | +44.44% | Beat | 0.0% | 18 | 2 up, 11 down | Aug 6, 2026 | $898.00M |
| Mar 31, 2026 | $0.27 | $0.27 | $0.22 - $0.40 | 0.00% | In line | -37.2% | 15 | 0 up, 5 down | May 5, 2026 | $880.00M |
| Dec 31, 2025 | $0.27 | $0.28 | $0.25 - $0.44 | -3.57% | Miss | +3.8% | 16 | 0 up, 2 down | Feb 26, 2026 | $961.00M |
| Sep 30, 2025 | $0.37 | $0.45 | $0.42 - $0.49 | -17.78% | Miss | -26.0% | 16 | 1 up, 1 down | Nov 6, 2025 | $904.00M |
| Jun 30, 2025 | $0.52 | $0.50 | $0.49 - $0.52 | +4.00% | Beat | +6.1% | 14 | 4 up, 0 down | Aug 7, 2025 | $936.00M |
| Mar 31, 2025 | $0.43 | $0.30 | $0.23 - $0.36 | +43.33% | Beat | +2.4% | 17 | 1 up, 2 down | May 8, 2025 | $879.00M |
| Dec 31, 2024 | $0.26 | $0.43 | $0.41 - $0.51 | -40.09% | Miss | -40.9% | 15 | 0 up, 1 down | Feb 27, 2025 | $905.00M |
| Sep 30, 2024 | $0.50 | $0.48 | $0.40 - $0.50 | +4.17% | Beat | +2.0% | 9 | 2 up, 0 down | Nov 7, 2024 | $951.00M |
| Jun 30, 2024 | $0.49 | $0.49 | $0.47 - $0.54 | 0.00% | In line | -3.9% | 13 | 2 up, 2 down | Jul 31, 2024 | $984.00M |
| Mar 31, 2024 | $0.42 | $0.42 | $0.40 - $0.46 | 0.00% | In line | +7.7% | 14 | 1 up, 0 down | May 2, 2024 | $953.00M |
| Dec 31, 2023 | $0.44 | $0.43 | $0.42 - $0.46 | +2.33% | Beat | -4.3% | 13 | 0 up, 0 down | Feb 29, 2024 | $1.01B |
| Sep 30, 2023 | $0.49 | $0.48 | $0.47 - $0.50 | +2.08% | Beat | +19.5% | 11 | 1 up, 1 down | Nov 2, 2023 | $947.00M |
| Jun 30, 2023 | $0.51 | $0.43 | $0.41 - $0.44 | +18.60% | Beat | -26.1% | 12 | 1 up, 0 down | Aug 2, 2023 | $1.03B |
| Mar 31, 2023 | $0.39 | $0.34 | $0.32 - $0.37 | +14.71% | Beat | -25.0% | 12 | 0 up, 0 down | May 3, 2023 | $978.00M |
| Dec 31, 2022 | $0.46 | $0.32 | $0.30 - $0.35 | +43.75% | Beat | -39.5% | 12 | 1 up, 0 down | Feb 28, 2023 | $983.00M |
| Sep 30, 2022 | $0.41 | $0.58 | $0.41 - $0.65 | -29.31% | Miss | -39.7% | 10 | 0 up, 1 down | Nov 14, 2022 | $947.00M |
| Jun 30, 2022 | $0.69 | $0.56 | $0.49 - $0.63 | +23.21% | Beat | -2.8% | 11 | 3 up, 0 down | Sep 24, 2022 | $1.02B |
| Mar 31, 2022 | $0.52 | $0.55 | $0.49 - $0.70 | -5.45% | Miss | -27.8% | 12 | 0 up, 0 down | May 10, 2022 | $969.00M |
| Dec 31, 2021 | $0.76 | $0.79 | $0.73 - $0.82 | -3.80% | Miss | -12.6% | 14 | N/A | Feb 28, 2022 | $1.10B |
| Sep 30, 2021 | $0.68 | $0.65 | $0.60 - $0.70 | +4.62% | Beat | +1.5% | 12 | N/A | Nov 4, 2021 | $1.04B |
| Jun 30, 2021 | $0.71 | $0.66 | $0.55 - $0.69 | +7.58% | Beat | N/A | 13 | N/A | Aug 5, 2021 | $1.06B |
| Mar 31, 2021 | $0.72 | $0.56 | $0.47 - $0.61 | +28.57% | Beat | +67.4% | 14 | N/A | May 6, 2021 | $1.03B |
| Dec 31, 2020 | $0.87 | $0.64 | $0.57 - $0.70 | +35.94% | Beat | +19.2% | 15 | N/A | Mar 1, 2021 | $1.09B |
| Sep 30, 2020 | $0.67 | $0.33 | $0.15 - $0.53 | +103.03% | Beat | +17.5% | 15 | N/A | Nov 5, 2020 | $883.00M |
| Jun 30, 2020 | -$0.18 | -$0.05 | -$0.22 - $0.21 | -260.00% | Miss | -127.3% | 15 | N/A | Aug 6, 2020 | $491.00M |
| Mar 31, 2020 | $0.43 | $0.39 | $0.12 - $0.61 | +10.26% | Beat | -12.2% | 14 | N/A | May 8, 2020 | $874.00M |
| Dec 31, 2019 | $0.73 | $0.75 | $0.72 - $0.77 | -2.67% | Miss | +25.9% | 14 | N/A | Mar 2, 2020 | $1.10B |
| Sep 30, 2019 | $0.57 | $0.50 | $0.46 - $0.59 | +14.00% | Beat | +50.0% | 17 | N/A | Nov 7, 2019 | $962.10M |
| Jun 30, 2019 | $0.66 | $0.62 | $0.57 - $0.67 | +6.45% | Beat | +10.0% | 16 | N/A | Aug 2, 2019 | $1.01B |
| Mar 31, 2019 | $0.49 | $0.39 | $0.33 - $0.49 | +25.64% | Beat | +8.9% | 14 | N/A | May 3, 2019 | $946.20M |
| Dec 31, 2018 | $0.58 | $0.54 | $0.49 - $0.56 | +7.41% | Beat | -29.3% | 13 | N/A | Mar 1, 2019 | $1.06B |
| Sep 30, 2018 | $0.38 | $0.46 | N/A | -17.39% | Miss | -45.7% | N/A | N/A | Nov 8, 2018 | $928.40M |
| Jun 30, 2018 | $0.60 | $0.59 | $0.55 - $0.61 | +1.69% | Beat | -7.7% | 15 | N/A | Aug 7, 2018 | $1.04B |
| Mar 31, 2018 | $0.45 | $0.42 | $0.40 - $0.46 | +7.14% | Beat | -8.2% | 15 | N/A | May 6, 2018 | $956.10M |
| Dec 31, 2017 | $0.82 | $0.81 | $0.80 - $0.83 | +1.23% | Beat | +22.4% | 14 | N/A | Mar 1, 2018 | $1.09B |
| Sep 30, 2017 | $0.70 | $0.65 | $0.64 - $0.68 | +7.69% | Beat | +6.1% | 13 | N/A | Nov 3, 2017 | $1.01B |
| Jun 30, 2017 | $0.65 | $0.65 | $0.59 - $0.73 | 0.00% | In line | -14.5% | 15 | N/A | Aug 9, 2017 | $992.70M |
| Mar 31, 2017 | $0.49 | $0.50 | N/A | -2.00% | Miss | -29.0% | N/A | N/A | May 9, 2017 | $900.50M |
| Dec 31, 2016 | $0.67 | $0.65 | N/A | +3.08% | Beat | +3.1% | N/A | N/A | Feb 17, 2017 | $996.50M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $1.59, down 4.8% from the year before. It was $2.78 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $1.59 | -4.8% |
| Dec 31, 2024 | $1.67 | -8.7% |
| Dec 31, 2023 | $1.83 | -12.0% |
| Dec 31, 2022 | $2.08 | -27.5% |
| Dec 31, 2021 | $2.87 | +60.3% |
| Dec 31, 2020 | $1.79 | -26.9% |
| Dec 31, 2019 | $2.45 | +21.9% |
| Dec 31, 2018 | $2.01 | -24.4% |
| Dec 31, 2017 | $2.66 | -4.3% |
| Dec 31, 2016 | $2.78 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,800 words across 9 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 4,762 | 9 | |
| 2026Q2 | Jun 30, 2026 | 6,170 | 19 | |
| 2026Q1 | Mar 31, 2026 | 7,527 | 16 | |
| 2025Q4 | Dec 31, 2025 | 7,360 | 16 | |
| 2025Q3 | Sep 30, 2025 | 6,941 | 14 | |
| 2025Q2 | Jun 30, 2025 | 7,959 | 16 | |
| 2025Q1 | Mar 31, 2025 | 8,169 | 13 | |
| 2024Q4 | Dec 31, 2024 | 8,932 | 13 |
2026Q3 Earnings Call
Opening remarks
Suzanne Hatcher Investor Relations Thank you, Stephanie. Welcome to the DENTSPLY SIRONA third quarter 2026 earnings call. Joining me for today's call are Dan Scavilla, President and Chief Executive Officer, and John Fortson, Executive Vice President and Chief Financial Officer. I'd like to remind you that an earnings press release and slide presentation related to the call are available on the Investors section of our website at www.dentsplysirona.com. Before we begin, please take a moment to read the forward-looking statements in our earnings press release. During today's call, we may make certain forward-looking statements that reflect our current views about future performance and financial results. We base these statements and certain assumptions and expectations on future events that are subject to risks and uncertainties. Our most recently filed Form 10-K and any updated information in subsequent Form 10-Q or other SEC filings list some of the most important risk factors that could cause actual results to differ from our predictions. On today's call, our remarks will be based on non-GAAP financial results. We believe that non-GAAP financial measures offer investors valuable additional insights into our business's financial performance, enable the comparison of financial results between periods where certain items may vary independently of business performance, and enhance transparency regarding key metrics utilized by management in operating our business. Please refer to our press release for the reconciliation between GAAP and non-GAAP results. Comparisons provided are to the prior year quarter unless otherwise noted. A webcast replay of today's call will be available on the Investors section of the company's website following this call. With that, I will now turn the call over to Dan.
Dan Scavilla President and Chief Executive Officer Thank you, Suzanne, and good afternoon, everyone. We continue to advance our Return-to-Growth Action Plan in the third quarter. We expanded customer access, strengthened our commercial organization, and increased investment in clinical education and innovation. Wellspect Healthcare delivered record sales, and we are seeing green shoots in parts of our U.S. dental business. We are making progress, but our results are not yet where they need to be. Our priority is now turning early gains into broader sustained improvement through stronger execution. We now expect full-year net sales of approximately $3.5 billion versus the range of $3.5 billion-$3.6 billion previously, and adjusted EPS of $1.20-$1.30 from $1.40-$1.50, excluding the $0.17 one-time gain from tariff refunds. Additional cost actions have not fully offset business pressures as we continue to invest in our sales force, clinical education, and innovation. As stated before, these investments will continue because they are essential to returning to sustainable growth. Before I turn the call over, John joined us in July and has now completed his first full quarter with DENTSPLY SIRONA.
Frequently Asked Questions About XRAY
When is Dentsply Sirona's next earnings date?
Dentsply Sirona's next earnings report is expected for Feb 24, 2027.
Did XRAY beat earnings estimates last quarter?
No. Dentsply Sirona reported EPS of $0.29 for the quarter ended Sep 30, 2026, below the $0.30 estimate by 3.33%.
What EPS do analysts expect from XRAY next quarter?
The consensus EPS estimate for Dentsply Sirona for the quarter ending Dec 31, 2026 is $0.31 from 18 analysts, with estimates from $0.16 to $0.49.
How often does XRAY beat earnings estimates?
Dentsply Sirona beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of +3.38%.
XRAY pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts